Your session is about to expire
← Back to Search
Nudge for Pre-eclampsia (REMIND Trial)
N/A
Waitlist Available
Led By Jourdan E Triebwasser, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months postpartum
Awards & highlights
No Placebo-Only Group
Summary
This trial will examine whether sending electronic reminders to obstetric care providers (nudge) can improve postpartum counseling and follow-up with preventative care providers for women with HDP.
Eligible Conditions
- Pre-Eclampsia, Severe
- Preeclampsia
- Prophylaxis of Preeclampsia
- Hypertension
- Pre-eclampsia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months postpartum
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months postpartum
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Patients With Documented Counseling on Transitions of Care
Secondary study objectives
Nudge Message Opened Within 1 Week of Receipt
Number of Participants With Postpartum Visit Notes That Used Example Text
Number of Patients With Documented Counseling on Cardiovascular Disease (CVD) Risk at the Postpartum Visit
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: NudgeExperimental Treatment1 Intervention
Obstetric care providers will receive electronic prompts (nudge) for participants in this arm
Group II: Usual careActive Control1 Intervention
Usual postpartum follow-up with visit at 4-12 weeks postpartum
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nudge
2022
N/A
~56380
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,082 Previous Clinical Trials
42,727,287 Total Patients Enrolled
Jourdan E Triebwasser, MDPrincipal InvestigatorUniversity of Pennsylvania
Share this study with friends
Copy Link
Messenger